We are live on ! Find out more
CAG

Csenge Advisory Group Portfolio holdings

AUM $2.18B
1-Year Est. Return 16.73%
This Fund
S&P 500
This Quarter Est. Return
+1.3%
1 Year Est. Return
+16.73%
3 Year Est. Return
+51.88%
5 Year Est. Return
+54.25%
10 Year Est. Return
AUM
$365M
AUM Growth
+$71M
Cap. Flow
+$70.6M
Cap. Flow %
19.35%
Top 10 Hldgs %
40.41%
Holding
293
New
100
Increased
121
Reduced
42
Closed
26
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BMY icon
126
Bristol-Myers Squibb
BMY
$127B
$572K 0.16%
11,269
-4,839
-30% -$227K
SCHG icon
127
Schwab US Large-Cap Growth ETF
SCHG
$58.5B
$572K 0.16%
54,464
-632
-1% -$6.66K
MDT icon
128
Medtronic
MDT
$107B
$571K 0.16%
5,259
+268
+5% +$28K
CME icon
129
CME Group
CME
$92.2B
$565K 0.15%
2,672
+1,251
+88% +$261K
ABT icon
130
Abbott
ABT
$180B
$564K 0.15%
6,743
-1,713
-20% -$146K
MS icon
131
Morgan Stanley
MS
$337B
$559K 0.15%
13,088
+4,017
+44% +$172K
VFC icon
132
VF Corp
VFC
$6.68B
$548K 0.15%
6,154
+390
+7% +$33.3K
PNC icon
133
PNC Financial Services
PNC
$100B
$541K 0.15%
3,857
+399
+12% +$54.1K
AWI icon
134
Armstrong World Industries
AWI
$6.86B
$538K 0.15%
5,567
RWR icon
135
State Street SPDR Dow Jones REIT ETF
RWR
$1.93B
$537K 0.15%
+5,137
New +$524K
XHB icon
136
State Street SPDR S&P Homebuilders ETF
XHB
$1.74B
$532K 0.15%
12,061
-1,029
-8% -$43.2K
RY icon
137
Royal Bank of Canada
RY
$291B
$529K 0.15%
6,518
-1,512
-19% -$118K
EMN icon
138
Eastman Chemical
EMN
$7.8B
$526K 0.14%
7,126
+2,589
+57% +$186K
UDR icon
139
UDR
UDR
$12.9B
$524K 0.14%
10,818
+3,266
+43% +$154K
CINF icon
140
Cincinnati Financial
CINF
$28.3B
$516K 0.14%
4,420
+927
+27% +$102K
PFE icon
141
Pfizer
PFE
$140B
$516K 0.14%
15,133
-8,213
-35% -$299K
LIN icon
142
Linde
LIN
$237B
$511K 0.14%
2,641
+881
+50% +$171K
VMBS icon
143
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.4B
$510K 0.14%
+9,566
New +$507K
TT icon
144
Trane Technologies
TT
$106B
$507K 0.14%
4,115
+748
+22% +$91.3K
AMT icon
145
American Tower
AMT
$77.7B
$497K 0.14%
2,249
+219
+11% +$47.8K
ORCL icon
146
Oracle
ORCL
$331B
$497K 0.14%
9,032
+955
+12% +$52.8K
XRT icon
147
State Street SPDR S&P Retail ETF
XRT
$365M
$495K 0.14%
+11,674
New +$484K
WEC icon
148
WEC Energy
WEC
$37.7B
$493K 0.14%
5,179
-34
-0.7% -$3.06K
DIS icon
149
Walt Disney
DIS
$165B
$492K 0.13%
3,776
+757
+25% +$105K
TLT icon
150
iShares 20+ Year Treasury Bond ETF
TLT
$42.1B
$491K 0.13%
+3,429
New +$477K

Similar funds

Csenge Advisory Group's Q3 2019 Portfolio in Review

As of Q3 2019, Csenge Advisory Group held 293 positions worth $365M, up 24% from $294M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Csenge Advisory Group deployed $70.6M of net new capital in Q3 2019, opening 100 new positions and adding to 121 existing holdings. Its largest new stake was First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF: 88,560 shares worth $4.61M.

By sector, the portfolio is most concentrated in Financials at 4.3% of assets, down from 5.4% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was iShares MSCI Emerging Markets Min Vol Factor ETF, an estimated $996K trimmed.

  • Csenge Advisory Group's largest Q3 2019 buy was First Trust Exchange-Traded Fund IV First Trust Low Duration Opportunities ETF: 88,560 shares worth $4.61M.
  • Csenge Advisory Group added most to Flaherty & Crumrine Preferred and Income Securities Fund in Q3 2019, an estimated $4.59M increase.
  • Csenge Advisory Group's biggest Q3 2019 reduction was iShares MSCI Emerging Markets Min Vol Factor ETF, cutting an estimated $996K.
  • Csenge Advisory Group fully exited iShares 7-10 Year Treasury Bond ETF in Q3 2019, selling an estimated $4.26M.
  • Csenge Advisory Group's ten largest holdings make up 40% of its $365M portfolio in Q3 2019.
  • Csenge Advisory Group opened 100 new positions and closed 26 in Q3 2019.
  • Csenge Advisory Group's portfolio value rose 24% quarter-over-quarter to $365M.

Based on Csenge Advisory Group's 13F filing for Q3 2019, filed 14 Nov 2019.